NCT03220893View on ClinicalTrials.gov

Molecular Breast Imaging and Digital Breast Tomosynthesis in Screening Patients With Dense Breast Tissue

NACompletedINTERVENTIONAL
Enrollment

3,023

Participants

Timeline

Start Date

June 14, 2017

Primary Completion Date

September 30, 2024

Study Completion Date

November 1, 2024

Conditions
Breast Carcinoma
Interventions
PROCEDURE

Digital Tomosynthesis Mammography

Undergo DBT

RADIATION

Scintimammography

Undergo MBI

Trial Locations (5)

43623

Toledo Clinic Cancer Centers-Toledo, Toledo

48202

Henry Ford Hospital, Detroit

54601

Mayo Clinic Health System-Franciscan Healthcare, La Crosse

55905

Mayo Clinic in Rochester, Rochester

77030

M D Anderson Cancer Center, Houston

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

Susan G. Komen Breast Cancer Foundation

OTHER

collaborator

National Cancer Institute (NCI)

NIH

lead

Mayo Clinic

OTHER

NCT03220893 - Molecular Breast Imaging and Digital Breast Tomosynthesis in Screening Patients With Dense Breast Tissue | Biotech Hunter | Biotech Hunter